151 related articles for article (PubMed ID: 27888704)
21. Analysis of ERCC2/XPD functional polymorphisms in systemic lupus erythematosus.
Wan L; Lin YJ; Sheu JJ; Huang CM; Tsai Y; Tsai CH; Wong W; Tsai FJ
Int J Immunogenet; 2009 Feb; 36(1):33-7. PubMed ID: 19055600
[TBL] [Abstract][Full Text] [Related]
22. DNA repair gene ERCC2 polymorphisms and associations with breast and ovarian cancer risk.
Bernard-Gallon D; Bosviel R; Delort L; Fontana L; Chamoux A; Rabiau N; Kwiatkowski F; Chalabi N; Satih S; Bignon YJ
Mol Cancer; 2008 May; 7():36. PubMed ID: 18454848
[TBL] [Abstract][Full Text] [Related]
23. Association of genetic polymorphisms in DNA repair pathway genes with non-small cell lung cancer risk.
Qian B; Zhang H; Zhang L; Zhou X; Yu H; Chen K
Lung Cancer; 2011 Aug; 73(2):138-46. PubMed ID: 21195504
[TBL] [Abstract][Full Text] [Related]
24. Genetic variability of genes in NER pathway influences the treatment outcome of gastric cancer.
Xue MH; Li GY; Wu XJ; Zhang CX; Zhang CF; Zhu KX
Int J Clin Exp Pathol; 2015; 8(5):5563-9. PubMed ID: 26191265
[TBL] [Abstract][Full Text] [Related]
25. Polymorphism of the DNA repair gene ERCC2 Lys751Gln and risk of lung cancer in a northeastern Chinese population.
Yin J; Vogel U; Ma Y; Guo L; Wang H; Qi R
Cancer Genet Cytogenet; 2006 Aug; 169(1):27-32. PubMed ID: 16875933
[TBL] [Abstract][Full Text] [Related]
26. Association of single nucleotide polymorphisms of DNA repair genes in NER pathway and susceptibility to pancreatic cancer.
Zhao F; Shang Y; Zeng C; Gao D; Li K
Int J Clin Exp Pathol; 2015; 8(9):11579-86. PubMed ID: 26617894
[TBL] [Abstract][Full Text] [Related]
27. Single nucleotide polymorphisms of the DNA repair gene XPD/ERCC2 alter mRNA expression.
Wolfe KJ; Wickliffe JK; Hill CE; Paolini M; Ammenheuser MM; Abdel-Rahman SZ
Pharmacogenet Genomics; 2007 Nov; 17(11):897-905. PubMed ID: 18075460
[TBL] [Abstract][Full Text] [Related]
28. Impact of RAD51 G135C and XRCC1 Arg399Gln polymorphisms on ovarian carcinoma risk in Serbian women.
Malisic EJ; Krivokuca AM; Boljevic IZ; Jankovic RN
Cancer Biomark; 2015; 15(5):685-91. PubMed ID: 26406958
[TBL] [Abstract][Full Text] [Related]
29. The effect of tobacco, XPC, ERCC2 and ERCC5 genetic variants in bladder cancer development.
Rouissi K; Bahria IB; Bougatef K; Marrakchi R; Stambouli N; Hamdi K; Cherif M; Ben Slama MR; Sfaxi M; Othman FB; Chebil M; Elgaaied AB; Ouerhani S
BMC Cancer; 2011 Mar; 11():101. PubMed ID: 21426550
[TBL] [Abstract][Full Text] [Related]
30. XRCC3 Thr241Met and XPD Lys751Gln gene polymorphisms and risk of clear cell renal cell carcinoma.
Loghin A; Bănescu C; Nechifor-Boila A; Chibelean C; Orsolya M; Nechifor-Boila A; Tripon F; Voidazan S; Borda A
Cancer Biomark; 2016; 16(2):211-7. PubMed ID: 26682510
[TBL] [Abstract][Full Text] [Related]
31. Polymorphisms in the promoter regions of the matrix metalloproteinases-1, -3, -7, and -9 and the risk of epithelial ovarian cancer in China.
Li Y; Jin X; Kang S; Wang Y; Du H; Zhang J; Guo W; Wang N; Fang S
Gynecol Oncol; 2006 Apr; 101(1):92-6. PubMed ID: 16278009
[TBL] [Abstract][Full Text] [Related]
32. HapMap-based study of the DNA repair gene ERCC2 and lung cancer susceptibility in a Chinese population.
Yin J; Vogel U; Ma Y; Qi R; Wang H
Carcinogenesis; 2009 Jul; 30(7):1181-5. PubMed ID: 19406934
[TBL] [Abstract][Full Text] [Related]
33. A pooled analysis of the ERCC2 Asp312Asn polymorphism and esophageal cancer susceptibility.
Wen F; Zhao Z; Liu C; Yin Q; Weng J; Wang Y; Ma Y
Tumour Biol; 2014 Apr; 35(4):2959-65. PubMed ID: 24234258
[TBL] [Abstract][Full Text] [Related]
34. Interleukin-1 receptor antagonist gene polymorphism in epithelial ovarian cancer.
Sehouli J; Mustea A; Koensgen D; Lichtenegger W
Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1205-8. PubMed ID: 14652282
[TBL] [Abstract][Full Text] [Related]
35. Association between the ERCC2 rs13181 polymorphism and the risk of glioma: a meta-analysis.
Jia TL; Wu HJ; Wang HB; Ma WB; Xing B
Genet Mol Res; 2015 Oct; 14(4):12577-84. PubMed ID: 26505408
[TBL] [Abstract][Full Text] [Related]
36. Polymorphisms in the two helicases ERCC2/XPD and ERCC3/XPB of the transcription factor IIH complex and risk of lung cancer: a case-control analysis in a Chinese population.
Hu Z; Xu L; Shao M; Yuan J; Wang Y; Wang F; Yuan W; Qian J; Ma H; Wang Y; Liu H; Chen W; Yang L; Jing G; Huo X; Chen F; Jin L; Wei Q; Wu T; Lu D; Huang W; Shen H
Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1336-40. PubMed ID: 16835333
[TBL] [Abstract][Full Text] [Related]
37. ERCC2 rs13181 polymorphism association with glioma susceptibility in a Chinese population.
Gao X; Tang YJ; Zhang GF; Yu L; Qi ST
Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27323065
[TBL] [Abstract][Full Text] [Related]
38. Polymorphisms in nucleotide excision repair genes and susceptibility to colorectal cancer in the Polish population.
Paszkowska-Szczur K; Scott RJ; Górski B; Cybulski C; Kurzawski G; Dymerska D; Gupta S; van de Wetering T; Masojć B; Kashyap A; Gapska P; Gromowski T; Kładny J; Lubiński J; Dębniak T
Mol Biol Rep; 2015 Mar; 42(3):755-64. PubMed ID: 25391773
[TBL] [Abstract][Full Text] [Related]
39. [Association of three single nucleotide polymorphisms of the E-cadherin gene with susceptibility to epithelial ovarian carcinoma].
Liang J; Li Y; Wang N
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Apr; 25(2):183-6. PubMed ID: 18393242
[TBL] [Abstract][Full Text] [Related]
40. Polymorphisms in the DNA repair genes XRCC1 and ERCC2, smoking, and lung cancer risk.
Zhou W; Liu G; Miller DP; Thurston SW; Xu LL; Wain JC; Lynch TJ; Su L; Christiani DC
Cancer Epidemiol Biomarkers Prev; 2003 Apr; 12(4):359-65. PubMed ID: 12692111
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
